Related Experiment Video

Updated: Aug 13, 2026

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
19:57

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on: March 30, 2014

Treating systemic fungal infections in AIDS patients. Prolonging life against the odds

W M Scheld1

  • 1Division of Infectious Diseases, University of Virginia Health Sciences Center, Charlottesville 22908.

Postgraduate Medicine
|December 1, 1990
PubMed

Insights

Systemic fungal infections pose a significant threat to immunocompromised individuals, especially those with acquired immunodeficiency syndrome (AIDS). New diagnostic tests and less toxic antifungal treatments offer improved management and quality of life for these patients.

Area of Science:

  • Medical Mycology
  • Infectious Diseases
  • Immunocompromised Host Management

Background:

  • Fungal infections are a leading cause of mortality in immunocompromised patients, particularly those with acquired immunodeficiency syndrome (AIDS).
  • Accurate and rapid diagnosis of systemic mycoses is challenging, often necessitating empirical antifungal therapy.
  • Current antifungal agents present limitations due to toxicity or ineffectiveness against deep-seated infections.

Purpose of the Study:

  • To review the challenges and advancements in managing systemic fungal infections in the context of a growing AIDS patient population.
  • To highlight the development of new diagnostic tools and therapeutic agents for fungal infections.

Main Methods:

  • Literature review of current challenges in diagnosing and treating systemic fungal infections in immunocompromised patients.
  • Analysis of emerging diagnostic technologies, including antigen detection tests.
  • Evaluation of newer antifungal agents, focusing on triazoles and their efficacy and toxicity profiles.

Main Results:

  • The increasing prevalence of AIDS necessitates improved strategies for managing systemic mycoses.
  • New antigen detection tests are under development to aid in quicker diagnosis.
  • Triazole antifungal agents demonstrate improved efficacy and reduced toxicity compared to older treatments.

Conclusions:

  • Despite challenges, advancements in diagnostics and therapeutics are improving outcomes for patients with systemic fungal infections.
  • Appropriate treatment can significantly prolong life and enhance the quality of life for individuals with AIDS and fungal co-infections.

More Related Videos

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors05:46

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Published on: April 9, 2014

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice06:07

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice

Published on: October 6, 2022

Related Concept Videos

Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Candidiasis01:20

Candidiasis

Candidiasis is a fungal infection caused by opportunistic species of Candida. It can affect various anatomical sites, including the skin, oral cavity, nails, and genitourinary tract. Among its forms, vaginal candidiasis is the most common type of mucosal infection. It typically results from the overgrowth of Candida albicans in the vaginal mucosa. Under normal conditions, C. albicans exists as a commensal organism within the vaginal microbiota, regulated by the dominance of lactobacilli, which...
Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...